BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright ©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 108702
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.108702
Table 1 Demographic data and clinical profile of study participants, n (%)/mean ± SD

Male (n = 6)
Female (n = 29)
Total (n = 35)
P value
Age (years)34.67 ± 10.5835.24 ± 12.4235.14 ± 11.980.92
Residence0.85
Local5 (83.33)25 (86.21)30 (85.71)
Regional1 (16.67)4 (13.79)5 (14.29)
Socio-economic status0.19
Upper1 (16.67)1 (3.45)2 (5.71)
Upper middle3 (50.00)11 (37.93)14 (40.00)
Lower middle1 (16.67)16 (55.17)17 (48.57)
Upper lower1 (16.67)1 (3.45)2 (5.71)
Occupation< 0.01
Farmer1 (16.67)0 (0.00)1 (2.86)
Homemaker1 (16.67)21 (72.41)22 (62.86)
Student2 (33.33)7 (24.14)9 (25.71)
Business2 (33.33)0 (0.00)2 (5.71)
Teacher0 (0.00)1 (3.45)1 (2.86)
Chief complaints0.82
HeadacheYes5 (83.33)23 (79.31)28 (80.00)
No1 (16.67)6 (20.69)7 (20.00)
Visual lossYes4 (66.67)24 (82.76)28 (80.00)0.37
No2 (33.33)5 (17.24)7 (20.00)
Others (hormonal disturbances)Yes5 (83.33)22 (75.86)27 (77.14)0.69
No1 (16.67)7 (24.14)8 (22.86)
Table 2 Retinal nerve fiber layer thickness (microns) in various tumor categories, mean ± SD
Tumour category
Retinal nerve fiber layer preoperative
At discharge
After 1.5 months
After 3 months
After 6 months
Pituitary adenoma79.7 ± 27.980.7 ± 27.881.2 ± 27.587.6 ± 27.683.3 ± 28.2
Craniopharyngioma102.0 ± 36.889.6 ± 34.267.5 ± 19.265.6 ± 18.267.8 ± 19.5
Meningioma59.4 ± 12.962.8 ± 12.463.7 ± 11.160.0 ± 8.961.2 ± 9.9
Others99.6 ± 32.289.1 ± 34.087.4 ± 31.886.9 ± 30.975.7 ± 27.0
Table 3 Distribution of retinal nerve fiber layer and ganglion cell complex thickness at baseline and follow-up visits, mean ± SD
Retinal nerve fiber layer thickness (micron)
Pre-operative
At discharge
After 1.5 months
After 3 months
After 6 months
Superior 110.19 ± 60.94 107.16 ± 43.8497.28 ± 31.1997.38 ± 29.1698.54 ± 31.98
Inferior 107.25 ± 53.04 102.84 ± 34.2595.87 ± 32.1693.58 ± 32.0795.97 ± 31.04
Nasal 68.04 ± 31.8565.79 ± 22.8861.53 ± 16.1360.78 ± 15.4161.83 ± 16.58
Temporal 51.51 ± 19.2550.72 ± 12.2951.16 ± 12.151.38 ± 10.3251.91 ± 9.97
Ganglion cell complex thickness (micron)65.67 ± 14.8564.85 ± 15.2365.26 ± 13.6965.43 ± 15.5966.19 ± 15.62
Table 4 Proportion of eyes with retinal nerve fiber layer and ganglion cell complex thinning, before and after surgery, n (%)
Preoperative
P value
Normal
Thinning
Total
Postoperative RNFL (superior)Normal 35 (50.7)4 (5.8)39 (56.5)0.25
Thinning 8 (11.6)22 (31.9)30 (43.5)
Total 43 (62.3)26 (37.7)69 (100)
RNFL (inferior)Normal 33 (47.8)3 (4.3)36 (52.2)< 0.05
Thinning12 (17.4)21 (30.4)33 (47.8)
Total 45 (65.2)24 (34.8)69 (100)
RNFL (nasal)Normal 42 (60.9)6 (8.7)48 (69.6)0.22
Thinning 11 (15.9)10 (14.5)21 (30.4)
Total 53 (76.8)16 (23.2)69 (100)
RNFL (temporal)Normal 32 (46.4)16 (23.2)48 (69.6)< 0.05
Thinning 6 (8.7)15 (21.7)21 (30.4)
Total 38 (55.1)31 (44.9)69 (100)
GCC Normal 20 (29.0)12 (17.4)32 (46.4)0.09
Thinning 5 (7.2)32 (46.4)37 (53.6)
Total 25 (36.2)44 (63.8)69 (100)
Table 5 Association of visual impairment with retinal nerve fiber layer and ganglion cell complex thickness, at baseline and final follow-up, mean ± SD

Mild visual impairment (6/6-6/18)
Moderate impairment (6/18-6/36)
Severe impairment to blind (6/36-3/60)
P value
Preoperative
RNFL thickness in micronSuperior 128.06 ± 65.9198.17 ± 24.3766.06 ± 18.34< 0.01
Inferior123.41 ± 54.42103.67 ± 24.4264.76 ± 27.67< 0.01
Nasal74.96 ± 34.56 59.67 ± 18.1452.29 ± 20.57< 0.05
Temporal55.89 ± 21.2342.83 ± 7.8142.7 ± 11.08< 0.05
Mean GCC thickness in micron70.5 ± 13.658 ± 10.0255.29 ± 13.51< 0.01
Postoperative (six-month follow-up)
RNFL thickness in micronSuperior105.98 ± 29.8495.25 ± 28.0663.18 ± 17.95< 0.01
Inferior102.61 ± 27.51101 ± 38.8461.54 ± 23.1< 0.01
Nasal63.2 ± 15.2869.75 ± 9.1852.18 ± 21.640.08
Temporal53.2 ± 9.1946.5 ± 8.1847.54 ± 12.890.12
Mean GCC thickness in micron69.9 ± 12.6767.25 ± 16.9847.54 ± 16.26< 0.01
Table 6 Univariate analysis of factors predictive of blindness
VariablesPreoperative
Final postoperative
Cor (95%CI)
P value
Cor (95%CI)
P value
Age 0.99 (0.93-1.06)0.9151.00 (0.92-1.08)0.991
Duration of symptoms 0.96 (0.86-1.06)0.450.98 (0.89-1.08)0.764
Preoperative mean RNFL thicknessSuperior 0.95 (0.92-0.98)< 0.010.96 (0.94-0.99)< 0.01
Inferior 0.96 (0.93-0.98)< 0.010.96 (0.94-0.98)< 0.01
Nasal 0.97 (0.93-1.00)0.060.98 (0.95-1.01)0.273
Temporal 0.93 (0.87-0.99)< 0.050.95 (0.88-1.01)0.11
Preoperative mean GCC thickness0.95 (0.91-0.99)< 0.050.95 (0.91-0.99)< 0.05
Tumor volume 1.00 (0.99-1.00)0.1281.00 (0.99-1.00)0.09
Duration of surgery1.61 (0.95-2.75)0.0781.57 (0.83-2.99)0.166
Surgical approach 3.23 (0.55-18.96)0.1944 (0.39-40.1)0.239